Nonin Medical, Inc.
$7.0K 17 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Atland Pharmaceuticals, LLC
Atland Pharmaceuticals, LLC reported $6,967.54 across General Payments, Research, and Ownership to 220 physicians and teaching hospitals across 220 transactions.
- $7.0K Below-median payer
- All-tracks total
- 220 Above-median volume
- Transactions
- 220 Above-median reach
- Recipients
- #1681
- of 1,925 companies
Atland Pharmaceuticals, LLC reported $6,967.54 across all CMS Open Payments tracks (General + Research + Ownership) to 220 physicians and teaching hospitals in Program Year 2024 - ranking #1681 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $6,967.54, averaging $31.67 per recipient.
Atland Pharmaceuticals, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
10/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer atland-pharmaceuticals-llc Atland Pharmaceuticals, LLC
$7.0K · #1681/1,925 · 0.0% industry · PY2024
- TOT $7.0K
- RANK #1681
- SHARE 0.0%
- TXN 220
- RCP 220
- CAT 2
- GEN $7.0K
- TOP1 8.8%
- PY 2024
Volume peers
Nearest volume peer: Nonin Medical, Inc. ($7.0K)
Atland Pharmaceuticals, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Atland Pharmaceuticals, LLC
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Atland Pharmaceuticals, LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $5.0K, accounting for 71.3% of this company's General Payments and 216 transactions.
General Payment Breakdown by Type
"Food and Beverage" leads Atland Pharmaceuticals, LLC's 2-category general-payment breakdown at $5.0K, 71.3% of the reported total.
How Atland Pharmaceuticals, LLC divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $5.0K | 216 | 71.3% |
| Compensation for Services Other Than Consulting | $2.0K | 4 | 28.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,310.42 (33.2%) of $6,967.54 in this company's General Payments records across 125 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Atland Pharmaceuticals, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Brandi Meads
$614.16 across 8 reported transactions
- 2
Johnny Young
$548.48 across 4 reported transactions
- 3
James Thacker
$500.00 across 1 reported transactions
- 4
Bryan King
$500.00 across 1 reported transactions
- 5
Haley Gibbs
$147.78 across 10 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Atland Pharmaceuticals, LLC's spend rank (#1681 of 1,925, bottom 13% by spend) and concentration rank (#1,463 of 1,838, bottom 20% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Balt USA, LLC : $457.3K total payments, HHI 303
- InspireMD Ltd : $11.0K total payments, HHI 302
- Synthes USA Products LLC : $235.8K total payments, HHI 302
- Paratek Pharmaceuticals, Inc. : $1.2M total payments, HHI 302
- Melinta Therapeutics, LLC : $573.7K total payments, HHI 300
- Avanos Medical : $867.2K total payments, HHI 298
- Atland Pharmaceuticals, LLC (this company) : $7.0K total payments, HHI 296
- Si-Bone, Inc. : $8.1M total payments, HHI 291
- Linde Gas & Equipment Inc. : $116.7K total payments, HHI 290
- Solventum Corporation : $6.0M total payments, HHI 289
- Enterra Medical, Inc. : $447.0K total payments, HHI 289
- Alcon Puerto Rico Inc : $5.0K total payments, HHI 288
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Atland Pharmaceuticals, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Atland Pharmaceuticals, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Atland Pharmaceuticals, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Epien Medical, Inc.
$7.0K 6 recipients
Compare payment profiles
Spirus Medical LLC
$6.9K 9 recipients
Compare payment profiles
VisionRT, Inc.
$6.9K 35 recipients
Compare payment profiles
Encision Inc
$7.1K 19 recipients
Compare payment profiles
Merge Healthcare Incorporated
$6.9K 135 recipients
Compare payment profiles
Put this to use
Atland Pharmaceuticals, LLC ranks #1681 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Atland Pharmaceuticals, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.